Anthony Fauci on what the US can learn from Australia s COVID-19 response â and vice versa
updated 38
AprApril 2021 at 10:50am
The lesson from the pandemic is prepare yourself as best you possibly can, Dr Fauci says.
(
Share
Print text only
Cancel
While the United States likes to describe itself as the leader of the free world, the coronavirus pandemic has hit it just as hard, if not worse, than many developing nations.
No-one knows this better than Anthony Fauci, America s top infectious disease expert, who on Wednesday spoke to an Australian audience as part of an event hosted by the Kirby Institute at the University of New South Wales.Loading
COVID-19 in Wisconsin: 10 new deaths, 922 new cases Photo: NIAID-RML via AP, File. FILE - This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. The sample was isolated from a patient in the U.S. According to an analysis by the federal Centers for Disease Control and Prevention published Tuesday, April 6, 2021 in JAMA Pediatrics, most children with a serious inflammatory illness linked to the coronavirus had initial COVID-19 infections with no symptoms or only mild ones, new U.S. research shows.
NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained.
As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management.
How did Remdesivir come into use?
Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease.
Hemanext Inc. Receives CE Mark Certification for Innovative Red Blood Cell (RBC) Processing & Storage System
Product now available in Norway, Blood centers in Italy, Switzerland, and
France expected to complete validations later this year
LEXINGTON, Mass., April 13, 2021 /PRNewswire/ Hemanext Inc., a privately held medical technology company, today announced it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the innovative medical device to be sold in European markets. Blood center validations required for the adoption of the Hemanext ONE RBC Processing and Storage System were completed in Norway in 2020. The company expects blood centers in Italy, Switzerland, and France to complete validations in 2021. Hemanext plans to secure additional validations and approvals in order to make the device available to healthcare professionals in other select European markets and in the Americas i
NEW DELHI: Amid an unprecedented surge in fresh Covid-19 infections, multiple states, including Maharashtra, Gujarat and Delhi, have flagged a shortage of anti-viral drug Remdesivir. The shortage prompted the government to halt the export of the drug and Remdesivir active pharmaceutical ingredients (APIs) till the Covid spread is contained.
As the country witnesses a ferocious resurgence of the virus, so has the demand for this medicine. Here are a few questions answered on the use of Remdesivir for Covid treatment and problems in the supply chain management.
How did Remdesivir come into use?
Remdesivir is an investigational antiviral drug to fight Sars-Cov 2, the virus that causes Covid-19. The US Food and Drug Administration (FDA) approved Gilead Sciences Inc’s antiviral therapy Remdesivir in October 2020, making it the first drug to obtain formal clearance for treating the coronavirus disease.